Log in to search using one of your social media accounts:

 

Lightstone Ventures raises $250m second fund
Lightstone Ventures this week said it raised $250 million for its second fund, $50 million more than it was aiming for. Menlo Park, Calif.- and Boston-based Lightstone said it plans to use the cash to back “companies developing therapies which have the potential to change the practice of medicine” and to found companies via its alliance with the Foundry medtech incubator and other strategic partners. The second fund has already made an investment, joining the $30 million Series A round for pharma startup Disarm Therapeutics. “The successful implementation of our strategy requires the ability to ident...
Source: Mass Device - September 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Wall Street Beat Lightstone Ventures Venture Capital/Private Equity Source Type: news

Metavention CEO hops to another VC-backed startup
Kevin Hykes has left his post as CEO of Metavention to take over as top executive at another venture capital backed startup that is now exploring opening a Twin Cities office. Hykes has been named CEO of Relievant Medsystems, a Sunnyvale, Calif.-based company that aims to treat lower back pain by destroying nerves. He was previously CEO of Metavention, whose headquarters moved from California to Eden Prairie under Hykes' leadership. Metavention develops technology to tr eat diabetes. Asked whether… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 21, 2017 Category: American Health Authors: Katharine Grayson Source Type: news

Singapore's MyDoc pulls in $5.2M for corporate health platform
Singapore-based startup MyDoc has collected $5.2 million in Series A funding. The investment was primarily received from Aliso Viejo, California-based digital and IT services provider UST Global, with additional funds coming from venture capital firm Wavemaker Partners and others. (Source: mobihealthnews)
Source: mobihealthnews - September 21, 2017 Category: Information Technology Source Type: news

How small companies can navigate partnerships in medtech
Partnering with larger players can prove essential to a small medtech company’s business strategy. But learning how to maneuver through collaborative relationships can be tricky.  Part of Philips Healthworks’ mission is to help young companies grow by teaching them valuable skills, like how to establish partnerships. Senior director Brian Rosnov spoke with MassDevice.com editor Sarah Faulkner in advance of his appearance at DeviceTalks Boston on Oct. 2.  What is Philips HealthWorks? As a venture capital fund, what qualities do you look for in a partner? While the Philips HealthWorks team is linked to ...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Wall Street Beat royalphilips Source Type: news

Andrew Witty jumps into biotech venture capital sector
Former chief of GlaxoSmithKline joins Hatteras Venture Partners (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 19, 2017 Category: Pharmaceuticals Source Type: news

Former GSK CEO joins venture capital firm Hatteras Venture Partners
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 19, 2017 Category: Pharmaceuticals Source Type: news

Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Mike Bonney, former CEO of Cubist Pharmaceuticals, to lead Kaleido through its next phase of growth $65 million in funds raised since its founding in 2015 Funds to advance Kaleido's robust pipeline of novel microbiome therapies BEDFORD, Mass., Sep... Biopharmaceuticals, Personnel, Venture Capital Kaleido Biosciences, microbiome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2017 Category: Pharmaceuticals Source Type: news

Cambridge VC firm Flagship targets $500M for latest fund
Flagship Pioneering could soon overtake Third Rock Ventures as the state ’s largest venture capital firm focused on life sciences investments. According to an SEC filing on Thursday, Cambridge-based Flagship is targeting $500 million for a new fund. It would be the firm’s seventh since it was founded in 1999, and bring its total under management from $1.75 billion c urrently to $2.25 billion. By comparison, Third Rock, which is based in Boston, has raised a total of $1.9 billion in its 10-year… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 15, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

DreamJay raises $2.3M to ramp up toward app launch
DreamJay, a San Francisco- and Warsaw, Poland-based sleep app developer, announced today that it has raised $2.3 million in Series A funding. Investors include the Joint Polish Investment Fund (JPIF), Poland ’s largest life science venture capital fund, and Nordic Makers, a Swedish fund. (Source: mobihealthnews)
Source: mobihealthnews - September 15, 2017 Category: Information Technology Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 14, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. How Boston Scientific is boosting medical device value Boston Scientific over the summer unveiled a new value-add for its implantable cardio devices: an online Trugevity calculator that lets physicians predict battery life. The...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Cheetah Medical raises $12m
Cheetah Medical said today it raised $11.8 million in an expanded Series C funding round as it looks to grow its US footprint. Financing was provided by existing investors including MVM Life Science Partners, Springfield Investment Management, Fletcher Spaght Ventures, HighCape Partners and Robert Basch Venture Capital, the Newton, Mass.-based company said. Cheetah Medical provides noninvasive hemodynamic monitoring devices and systems, including its Cheetah Nicom and Starlin SV technologies, which operate around a proprietary algorithm designed to allow physicians to examine a patient’s full hemodynamic profile...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cheetah Medical Source Type: news

Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
ROCKVILLE, Md., Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, a... Biopharmaceuticals, Venture Capital Synthetic Biologics, ribaxamase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

The State of Dermatology
(MedPage Today) -- One expert offers a different perspective on venture capital and the future of dermatology (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 11, 2017 Category: American Health Source Type: news

Is Medtronic Making Good on Its Post-Merger Promise?
Two years ago and some change, Medtronic sent shockwaves through the medical device world with the news of its $42.9 billion acquisition of Covidien through a tax inversion deal that moved the company’s corporate headquarters to Ireland and freed up $9.3 billion in cash that had previously been trapped overseas. The announcement came with a promise, however. As a direct benefit of the company’s new financial structure, Medtronic vowed to make $10 billion in U.S. technology investments over the coming decade in areas such as early stage venture capital investments, acquisitions, and R&D – above and bey...
Source: MDDI - September 8, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis Medical Device Business Source Type: news

Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
WOBURN, Massachusetts, September 8, 2017 -- (Healthcare Sales & Marketing Network) -- Replimune Group Inc., a biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a $55 million Series B f... Biopharmaceuticals, Oncology, Venture Capital Replimune Group, Immulytic , oncolytic immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2017 Category: Pharmaceuticals Source Type: news

Broncus Medical affiliate acquires Uptake Medical
Uptake Medical said yesterday that its InterVapor device for treating emphysema is back on the market in Europe after its acquisition for an undisclosed amount by an affiliate of Broncus Medical. Broncus set its purchase up under a new entity based in Seattle, Uptake Medical Technology, and plans to add markets in Australia and Asia to its commercial footprint in Europe by the end of the year. The InterVapor device uses heated water vapor to reduce lung volume in emphysema patients. Uptake won an expanded CE Mark in the European Union for InterVapor in August 2015. “2018 promises to be an exciting year for ...
Source: Mass Device - September 8, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Respiratory Wall Street Beat Broncus Medical Uptake Medical Source Type: news

Google parent backs machine-learning cancer treatment
Alphabet venture capital arm takes part in Gritstone $93m fundraising round (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 7, 2017 Category: Pharmaceuticals Source Type: news

Orbimed closes $551m Asia-focused healthcare fund
OrbiMed said this week it closed its 3rd Asian-focused healthcare private equity fund, having raised approximately $551 million in capital commitments. The new fund, the Asia Partners III, is slated to invest “broadly across the Asian healthcare industry,” focusing on growth stage product and services-oriented companies in China and India, according to the investment firm. “This new, larger fund reflects our enthusiasm for the investment opportunities in China and India, which have healthcare market growth rates far superior to most developed countries,” general partner Carter Neild said in a prepar...
Source: Mass Device - September 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News OrbiMed Venture Capital/Private Equity Source Type: news

Delphinus launches SoftVue clinical study
Tomographic ultrasound technology developer Delphinus Medical Technologies...Read more on AuntMinnie.comRelated Reading: Delphinus taps new VP of engineering Delphinus relocates corporate HQ Delphinus adds to executive lineup Delphinus wins $39.5M in venture capital Delphinus taps new VP (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 6, 2017 Category: Radiology Source Type: news

Hooks Johnston, local venture capitalist and philanthropist, dies at 55
When Betsy Edmunds met her future husband, Hooks Johnston, through friends at a bar in New York City in 1985, she couldn't believe two things about this tired and overworked investment banker — his name and how he spoke so earnestly about his family. "How many 22-year-old guys who are bigwigs working at Salomon Brothers meet a girl and talk about their grandmother and their sister?" Betsy Johnston said in an interview. "We started dating right after that." Johnston, a venture capital ist, corporate… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 5, 2017 Category: Pharmaceuticals Authors: Andy Medici Source Type: news

Stent Tek Closes Series a Investment Round for its ePATH AVF Device, Aiming to Improve Vascular Access for Haemodialysis
LONDON, August 30, 2017 -- (Healthcare Sales & Marketing Network) -- Stent Tek, a medical device company that is developing a minimally invasive catheter system for dialysis patients, announced today it has successfully closed a Series A funding round wit... Devices, Venture Capital Stent Tek, ePATH AVF, haemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2017 Category: Pharmaceuticals Source Type: news

ExplORer Surgical, the OS for the OR, Announces $3M Series A Financing
Funding to accelerate commercialization of interactive workflow management platform for surgery CHICAGO, Aug. 29, 2017 -- (Healthcare Sales & Marketing Network) -- ExplORer Surgical, a leading platform for intraoperative surgical and interventional pro... Devices, Surgery, Venture Capital, Personnel ExplORer Surgical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 29, 2017 Category: Pharmaceuticals Source Type: news

ARMO BioSciences Raises $67 Million in a Series C-1 Financing
Financing from New and Existing Investors Follows Encouraging Clinical Data Announced for Lead Product Candidate, AM0010, in Several Cancer Indications REDWOOD CITY, Calif., Aug. 29, 2017 -- (Healthcare Sales & Marketing Network) -- ARMO BioSciences, I... Biopharmaceuticals, Oncology, Venture Capital, Personnel ARMO BioSciences, pegilodecakin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 29, 2017 Category: Pharmaceuticals Source Type: news

Contact lens brand Hubble scores funding from FirstMark Capital, others
New York-area startups and venture capitalists are making funding deals with the hopes of creating the next profitable company. Here's one deal announced Tuesday: Who gets: Hubble, the New York-based direct-to-consumer contact lens brand, received a new round of financing. Amount raised:$10 million in new Series A funding. The company now has more than $30 million in venture capital financing. Who invests: FirstMark Capital, Greycroft Partners, Founders F und, Wildcat Capital Management and Two… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 28, 2017 Category: Biotechnology Authors: Anthony Noto Source Type: news

Boston Scientific, Medtronic join $30m SetPoint Medical Series D
SetPoint Medical said today it raised $30 million in a Series D equity financing round with funds slated to support continued development of its bioelectronic therapy for treating chronic inflammatory diseases. Funding in the round came from existing investors including NEA, Morgenthaler, Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), Topspin, Action Potential Venture Capital, the Valencia, Calif.-based company said. “We are grateful for the strong support from our investors who are aligned with our vision to commercialize life-changing bioelectronic medicines for patients with debilitating inflam...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Boston Scientific Medtronic SetPoint Medical Source Type: news

Access Vascular Secures $3.7 Million In Financing
Latest round of funding will advance HydroPICC™ development and regulatory pathway BEDFORD, Mass., Aug. 28, 2017 -- (Healthcare Sales & Marketing Network) -- Access Vascular, a medical device company developing innovative venous access devices that eli... Devices, Venture Capital Access Vascular, HydroPICC, peripherally inserted central catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 28, 2017 Category: Pharmaceuticals Source Type: news

MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
Genomics research and diagnostics company aims to accelerate biomarker discovery by leveraging the genetic diversity of the Indian population FOSTER CITY, Calif., Aug. 28, 2017 -- (Healthcare Sales & Marketing Network) -- MedGenome, a leading genomics ... Diagnostics, Venture Capital MedGenome, GenomeAsia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 28, 2017 Category: Pharmaceuticals Source Type: news

Venture capital investing is on the decline, but here's why Greensboro shouldn't worry
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 24, 2017 Category: American Health Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline. Here's why Boston shouldn't worry
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 23, 2017 Category: American Health Authors: Jeff Jeffrey Source Type: news

Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures
Merck Ventures Joins Investment Syndicate and the Board of Macrophage WINDSOR, England, August 23, 2017 -- (Healthcare Sales & Marketing Network) -- Macrophage Pharma Limited ('MPL') the immuno-oncology research and development company focused on macro... Biopharmaceuticals, Oncology, Venture Capital Macrophage Pharma, tumor microenvironment (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 23, 2017 Category: Pharmaceuticals Source Type: news

Channel Medsystems(R) Secures $14.1mm Financing for Office-Based Treatment of Heavy Menstrual Bleeding
EMERYVILLE, Calif., Aug. 23, 2017 -- (Healthcare Sales & Marketing Network) -- Channel Medsystems, developer of an innovative, physician office-based therapy for heavy menstrual bleeding, announced today that it has secured a $14.1mm Series C-1 financing.... Devices, Venture Capital Channel Medsystems, Cerene Cryotherapy, endometrial cryoablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 23, 2017 Category: Pharmaceuticals Source Type: news

Venture capital investing is on the decline. Here's why Dallas shouldn't worry
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 22, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline — Houston saw one of the biggest drops
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there are billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline — Houston saw one of the biggest drops
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there are billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association.… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 21, 2017 Category: American Health Authors: Jeff Jeffrey Source Type: news

How ABQ fares in VC funding (slideshow)
Venture capital spending continues to lag behind the record activity of recent years, but Albuquerque startups needn't worry; industry analysts say there's billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Jeff Jeffrey Source Type: news

How ABQ fares in VC funding (slideshow)
Venture capital spending continues to lag behind the record activity of recent years, but Albuquerque startups needn't worry; industry analysts say there's billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline, and here's why
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline, and here's why
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline. Here's why Baltimore shouldn't worry
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. Nationally, VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the Nat ional Venture… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline. Here's why Baltimore shouldn't worry
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. Nationally, VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the Nat ional Venture… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline — But not in Miami
Venture capital spending continues to lag behind the record activity of recent years, but the Miami area seems to be an exception for such investments. And industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline — But not in Miami
Venture capital spending continues to lag behind the record activity of recent years, but the Miami area seems to be an exception for such investments. And industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Charlotte saw big drop in venture investing last year — here's why you shouldn't worry
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10% from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Venture Capit al Association. Charlotte… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Jeff Jeffrey Source Type: news

Charlotte saw big drop in venture investing last year — here's why you shouldn't worry
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10% from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Venture Capit al Association. Charlotte… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline. Here's why Portland shouldn't worry (Interactive map)
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 18, 2017 Category: American Health Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline. Here's why Portland shouldn't worry (Interactive map)
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 18, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline nationwide and in Orlando. Here's why
​Coming off of several years of record levels of venture capital spending, 2017 is showing signs that investors have begun to tighten up on the amount of money they’re willing to spend to help new companies get going. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 18, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Venture capital investing is on the decline, and here's why
Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done. VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Ventur e Capital Association. Deal… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 18, 2017 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news

Artemis Health raises $16M in Series B funding for benefit optimization data platform
Artemis Health, which offers a benefit optimization data platform for employers, just received $16 million in Series B funding, led by an investment from F-Prime Capital, the venture capital funds of FMR LLC, the parent company of Fidelity Investments. There was also participation in the round from Maverick Ventures and Kickstart Seed Fund, both previous investors. (Source: mobihealthnews)
Source: mobihealthnews - August 16, 2017 Category: Information Technology Source Type: news